GNPX (Genprex, Inc. Common Stock) Stock Analysis - Analyst Ratings

Genprex, Inc. Common Stock (GNPX) is a publicly traded Healthcare sector company. As of May 20, 2026, GNPX trades at $0.79 with a market cap of $8.39M and a P/E ratio of -0.04. GNPX moved -1.47% today. Year to date, GNPX is -56.12%; over the trailing twelve months it is -94.52%. Its 52-week range spans $0.74 to $198.50. Rallies surfaces GNPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate GNPX?

The average price target is $0.00.

GNPX Key Metrics

Key financial metrics for GNPX
MetricValue
Price$0.79
Market Cap$8.39M
P/E Ratio-0.04
EPS$-17.40
Dividend Yield0.00%
52-Week High$198.50
52-Week Low$0.74
Volume211.51K
Avg Volume0
Revenue (TTM)$0
Net Income$-16.23M
Gross Margin0.00%

GNPX Analyst Consensus

GNPX analyst coverage data. Average price target: $0.00.

Latest GNPX News

Recent GNPX Insider Trades

  • LONGNECKER BRENT M sold 8 (~$9.84) on Apr 14, 2026.
  • LONGNECKER BRENT M sold 10 (~$12.3) on Apr 14, 2026.
  • Varner John Rodney bought 19.00K (~$20.05K) on Apr 21, 2023.

Common questions about GNPX

What do analysts rate GNPX?
The average price target is $0.00.
Does Rallies show GNPX price targets?
Yes. Rallies tracks GNPX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is GNPX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GNPX. It does not provide personalized investment advice.
GNPX

GNPX